Skip to main content

Table 2 Participant demographics

From: Living with frailty and haemodialysis: a qualitative study

  

N = 25

Age (years)

 

69 ± 10

Sex, n (%)

Female

13 (52%)

Male

12 (48%)

Ethnicity, n (%)

White British

13 (52%)

Asian or Asian British

10 (40%)

Caribbean

1 (4%)

Not stated

1 (4%)

Diagnosis, n (%)

Diabetic nephropathy

11 (44%)

Aetiology uncertain

6 (24%)

Chronic pyelonephritis

3 (12%)

Atypical hemolytic uremic syndrome

1 (4%)

Focal segmental glomerulosclerosis with nephrotic syndrome

1 (4%)

Henoch-Sconlein Purpura

1 (4%)

Minimal change nephropathy

1 (4%)

Polycystic kidney disease

1 (4%)

Charlson Co-morbidity Index

 

6 ± 2

Time on haemodialysis (months)

 

43 (IQR 16–85)

Number of medications

 

13 (IQR 10–16)

Clinical Frailty Scale (CFS) score, n (%)

CFS 4, Vulnerable

9 (36%)

CFS 5, Mildly frail

5 (20%)

CFS 6, Moderately frail

8 (32%)

CFS 7, Severely frail

3 (12%)

Number of falls in last six months

 

3 (IQR 2–4)

Previous transplant, n (%)

No

21 (84%)

Yes

4 (16%)

Active on transplant list, n (%)

No

22 (88%)

Yes

3 (12%)

Employment status, n (%)

Retired

21 (84%)

Unemployed

3 (12%)

Part-time employed

1 (4%)

Marital status, n (%)

Married

15 (60%)

Single

5 (20%)

Widowed

5 (20%)

Social circumstances, n (%)

Lives with spouse or partner

11 (44%)

Lives alone

9 (36%)

Lives with extended family

5 (20%)a

  1. Data are mean ± standard deviation or median (IQR) unless otherwise indicated
  2. a Demographic characteristics were extracted from participants medical records, Clinical Frailty Scale scoring was undertaken by the participants consultant nephrologist and information on falls and social circumstances were gathered from the participants